Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study

Contemporary Clinical Trials

Volumn 28, Issue 1, 2007, Pages 48-58

 

^a UITN)   (United States)

Author keywords

Behavioral therapy; Combined modality therapy; Drug therapy; Overactive bladder; Pelvic floor muscle exercises; Quality of life; Urinary incontinence

Indexed keywords

TOLTERODINE;

ARTICLE; BLADDER FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG UTILIZATION; DRUG WITHDRAWAL; EXERCISE; FEMALE; FLUID THERAPY; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; MORBIDITY; MUSCLE STRENGTH; OUTCOME ASSESSMENT; OVERACTIVE BLADDER QUESTIONNAIRE; PATIENT SATISFACTION; PELVIC FLOOR MUSCLE TRAINING; PELVIS FLOOR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHORT FORM 36; STATISTICAL SIGNIFICANCE; SUSTAINED DRUG RELEASE; URGE INCONTINENCE; URINE INCONTINENCE; UROGENITAL DISTRESS INVENTORY;

ADULT; BEHAVIOR THERAPY; BENZHYDRYL COMPOUNDS; CRESOLS; EXERCISE THERAPY; FEMALE; HUMANS; MULTICENTER STUDIES; MUSCARINIC ANTAGONISTS; PATIENT SATISFACTION; PHENYLPROPANOLAMINE; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 33751178010     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.06.002     Document Type: Article

References (23)

1. Fantl JA, Newman DK, Colling J, et al. Urinary Incontinence in Adults: Acute and Chronic Management. Clinical Practice Guideline, No. 2, 1996 Update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0682.
2. Wagner T.H., and Hu T.W. Economic costs of urinary incontinence in 1995. Urology 51 (1998) 355-361
3. Hunskaar S., and Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 39 (1991) 378-382
4. Coyne K.S., Zhou Z., Thompson C., and Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 92 (2003) 731-735
5. Seim A., Eriksen B.C., and Hunskaar S. A study of female urinary incontinence in general practice. Demography, medical history, and clinical findings. Scand J Urol Nephrol 30 (1996) 465-471
6. Borello-France D., and Burgio K.L. Nonsurgical treatment of urinary incontinence. Clin Obstet Gynecol 47 (2004) 70-82
7. Burgio K.L. Behavioral treatment options for urinary incontinence. Gastroenterology 126 (2004) 82-89
8. Herzog A.R., Diokno A.C., Brown M.B., Normolle D.P., and Brock B.M. Two-year incidence, remission, and change patterns of urinary incontinence in noninstitutionalized older adults. J Gerontol Med Sci 45 (1990) M67-M74
9. Bowden A., Colman S., Sabounjian L., et al. Psychometric validation of an urgency severity scale (IUSS) for patients with overactive bladder. International Continence Society, Abstract #119 (2003)
10. Shumaker S.A., Wyman J.F., Uebersax J.S., McClish D., and Fantl J.A. Health-related quality of life measures for women with urinary incontinence: the incontinence impact questionnaire and the urogenital distress inventory. Qual Life Res 3 (1994) 291-306
11. Coyne KA. Summary of the Validation of the OAB-q: A Disease-Specific Overactive Bladder Questionnaire. Unpublished Report for Pharmacia Corporation, Bethesda MD: MEDTAP International, Inc., 2002.
12. Ware J.E., Kosinski M., and Keller S.D. A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
13. Burgio K.L., Locher J.L., Goode P.S., et al. Behavior vs. drug treatment for urge urinary incontinence in older women. JAMA 280 (1998) 1995-2000
14. Burgio K.L., Goode P.S., Locher J.L., et al. Behavioral training with and without biofeedback in the treatment of urge incontinence of older women. A randomized controlled trial. JAMA 288 (2002) 2293-2299
15. Brink C.A., Wells T.J., Sampselle C.M., Taillie E.R., and Mayer R. A digital test for pelvic muscle strength in women with urinary incontinence. Nurs Res 43 (1994) 352-356
16. Furlong W., Feeny D., Torrance G.W., et al. Multiplicative multi-attribute utility function for the health utilities index mark 3 (HUI3) system: a technical report (1998), McMaster University Centre for Health Economics and Policy Analysis
17. Kobelt G. Economic considerations and outcome measurement in urge incontinence. Urology 50 6A Suppl (1997) 100-107
18. Bump R.C., Mattiasson A., Bo K., et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175 (1996) 10-17
19. Lan K.K.G., and DeMets D.L. Discrete sequential boundaries for clinical trials. Biometrika 70 (1983) 659-663
20. O'Brien P.C., and Fleming T.R. A multiple testing procedure for clinical trials. Biometrics 35 (1979) 549-556
21. Assmann S.F., Pocock S.J., Enos L.E., and Kasten L.E. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355 (2000) 1064-1069
22. Mattiasson A., Blaakaer J., Hoye K., Wein A.J., and and the Tolterodine Scandinavian Study Group. Simplified bladder training augments the effectiveness of tolterodine in patients with an overactive bladder. BJU Int 91 (2003) 54-60
23. Burgio K.L., Locher J.L., and Goode P.S. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc 48 (2000) 370-374